Sales of Lateral Flow Assays in Clinical Testing to Increase at 5% CAGR through 2032 Fact.MR's latest report on the global lateral flow assays market presents in-depth information about
Growing usage in human & animal vaccine production and in range of biopharmaceutical applications expanding profitable opportunitiesExtensive R&D in cell media culture technologies underpin
The Result meets the company's RMB 100 billion target for FY2021 with the company also delivering a strong start to FY2022 in the first quarterDespite ongoing issues related to COVID-19, the